PA
Pinnacle Associates’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,993
| Closed | -$250K | – | 846 |
|
|
2024
Q3 | $250K | Buy |
+3,993
| New | +$250K | ﹤0.01% | 726 |
|
|
2024
Q2 | – | Sell |
-5,303
| Closed | -$361K | – | 820 |
|
|
2024
Q1 | $361K | Buy |
5,303
+1,310
| +33% | +$89.3K | 0.01% | 653 |
|
|
2023
Q4 | $250K | Buy |
+3,993
| New | +$250K | ﹤0.01% | 736 |
|
|
2023
Q3 | – | Sell |
-4,316
| Closed | -$242K | – | 815 |
|
|
2023
Q2 | $242K | Buy |
+4,316
| New | +$242K | ﹤0.01% | 733 |
|
|
2022
Q4 | – | Sell |
-4,416
| Closed | -$289K | – | 763 |
|
|
2022
Q3 | $289K | Buy |
+4,416
| New | +$289K | 0.01% | 606 |
|